Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINAGLIPTIN vs LIOTHYRONINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINAGLIPTIN vs LIOTHYRONINE: Safety Overview

Metric LINAGLIPTIN LIOTHYRONINE
Total FAERS Reports 7,762 2,747
Deaths Reported 726 41
Death Rate 9.4% 1.5%
Hospitalizations 2,794 501
Average Patient Age 70.2 yrs 54.9 yrs
% Female Patients 51.8% 89.5%
FDA Approval Date Aug 31, 2021 Approved Prior to Jan 1, 1982
Manufacturer Novadoz Pharmaceuticals LLC SIGMAPHARM LABORATORIES, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription